SCHEMBL2449598

SCHEMBL2449598

N#CC(C(N)=O)=C1CCCCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.51
LMNA P02545 1/20 0.51
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 1/20 0.42
PTK2B Q14289 1/20 0.39
HPGD P15428 3/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 2/20 0.33
KDM4E B2RXH2 2/20 0.32
GRIK1 P39086 1/20 0.32
MAPT P10636 2/20 0.31
MEN1 O00255 1/20 0.30
MAPK1 P28482 1/20 0.30
KMT2A Q03164 1/20 0.30
MAPK10 P53779 1/20 0.30
ESR1 P03372 1/20 0.30
PGR P06401 1/20 0.30
CHRM2 P08172 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18726773 1.00 SMN1; SMN2 (0.51) SMN1; SMN2LMNAALDH1A1HSD17B10PTK2B
SCHEMBL11417303 0.98 SMN1; SMN2 (0.49) SMN1; SMN2LMNAALDH1A1HSD17B10PTK2B
SCHEMBL4545218 0.80 SMN1; SMN2 (0.53) SMN1; SMN2LMNAALDH1A1HSD17B10HPGD
SCHEMBL6836877 0.78 SMN1; SMN2 (0.51) SMN1; SMN2LMNAALDH1A1HSD17B10HPGD
SCHEMBL6622150 0.77 SMN1; SMN2 (0.50) SMN1; SMN2LMNAALDH1A1HSD17B10HPGD
SCHEMBL5641654 0.74 SMN1; SMN2 (0.51) SMN1; SMN2LMNAALDH1A1HSD17B10HPGD
SCHEMBL15804810 0.74 SMN1; SMN2 (0.47) SMN1; SMN2LMNAALDH1A1HSD17B10HPGD
SCHEMBL18726853 0.72 ALDH1A1 (0.48) SMN1; SMN2LMNAALDH1A1HSD17B10TSHR
SCHEMBL15804830 0.71 SMN1; SMN2 (0.45) SMN1; SMN2LMNAALDH1A1HSD17B10HPGD
SCHEMBL5642488 0.71 SMN1; SMN2 (0.49) SMN1; SMN2LMNAALDH1A1RAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732899-B1 PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE SERICHIM S R L (IT) 2011-09-21 EP claimed
US-7381823-B2 Process for preparing cyclohexanediacetic acid monoamide SERICHIM S.R.L. (IT) 2008-06-03 US claimed
US-20070208175-A1 PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE SERICHIM S.R.L. (IT) 2007-09-06 US claimed
EP-1732899-A2 PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE SERICHUM S.R.L. (IT) 2006-12-20 EP claimed
WO-2005090310-A2 PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE SERICHIM S.R.L. (IT) 2005-09-29 WO claimed
EP-1732899-B1 PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE SERICHIM S R L (IT) 2011-09-21 EP disclosed
EP-1732899-B1 PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE SERICHIM S R L (IT) 2011-09-21 EP disclosed
US-7381823-B2 Process for preparing cyclohexanediacetic acid monoamide SERICHIM S.R.L. (IT) 2008-06-03 US disclosed
US-20070208175-A1 PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE SERICHIM S.R.L. (IT) 2007-09-06 US disclosed
US-20070208175-A1 PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE SERICHIM S.R.L. (IT) 2007-09-06 US disclosed
EP-1732899-A2 PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE SERICHUM S.R.L. (IT) 2006-12-20 EP disclosed
WO-2005090310-A2 PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE SERICHIM S.R.L. (IT) 2005-09-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070208175-A1 PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE GNPAT, GMDS, PIGS SMN1; SMN2 3584/4885LMNA 3479/4885ALDH1A1 816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.